Eagle Pharmaceuticals, Inc. (EGRX)
0.75
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Eagle Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.2875 |
| March 31, 2023 | 0.3252 |
| December 31, 2022 | 0.2805 |
| September 30, 2022 | 0.2795 |
| June 30, 2022 | 0.2252 |
| March 31, 2022 | 0.1279 |
| December 31, 2021 | 0.169 |
| September 30, 2021 | 0.1713 |
| June 30, 2021 | 0.174 |
| March 31, 2021 | 0.1887 |
| December 31, 2020 | 0.2055 |
| September 30, 2020 | 0.2256 |
| June 30, 2020 | 0.2194 |
| March 31, 2020 | 0.8332 |
| December 31, 2019 | 0.2381 |
| September 30, 2019 | 0.2503 |
| June 30, 2019 | 0.2519 |
| March 31, 2019 | 0.2559 |
| December 31, 2018 | 0.2762 |
| September 30, 2018 | 0.2283 |
| June 30, 2018 | 0.2515 |
| March 31, 2018 | 0.2687 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.2667 |
| September 30, 2017 | 0.286 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -0.7491 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |